D. Depisch

3.5k total citations
82 papers, 2.7k citations indexed

About

D. Depisch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, D. Depisch has authored 82 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 22 papers in Surgery. Recurrent topics in D. Depisch's work include Cancer Treatment and Pharmacology (28 papers), Colorectal Cancer Treatments and Studies (26 papers) and Gastric Cancer Management and Outcomes (15 papers). D. Depisch is often cited by papers focused on Cancer Treatment and Pharmacology (28 papers), Colorectal Cancer Treatments and Studies (26 papers) and Gastric Cancer Management and Outcomes (15 papers). D. Depisch collaborates with scholars based in Austria, Germany and United States. D. Depisch's co-authors include Werner Scheithauer, Gabriela Kornek, Harald Rosén, Christian Sebesta, K. Haider, Markus Raderer, Bruno Schneeweiß, W. Kwasny, Fritz Lang and H. Ulrich-Pur and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

D. Depisch

79 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Depisch Austria 28 2.0k 939 895 395 386 82 2.7k
Tetsuhiko Shirasaka Japan 24 2.4k 1.2× 845 0.9× 1.9k 2.1× 749 1.9× 294 0.8× 102 3.5k
J. L. Misset France 27 2.1k 1.0× 452 0.5× 1.0k 1.2× 433 1.1× 566 1.5× 63 3.0k
Elizabeth Poplin United States 24 2.2k 1.1× 721 0.8× 1.2k 1.3× 681 1.7× 485 1.3× 80 3.2k
Rainer Porschen Germany 33 2.0k 1.0× 1.2k 1.3× 1.1k 1.2× 700 1.8× 359 0.9× 114 3.2k
Carles Pericay Spain 28 2.0k 1.0× 1.1k 1.2× 802 0.9× 593 1.5× 593 1.5× 138 2.9k
Roger Faroux France 23 1.7k 0.8× 599 0.6× 684 0.8× 311 0.8× 550 1.4× 98 2.5k
Roberto Petrioli Italy 28 1.6k 0.8× 855 0.9× 1.2k 1.4× 508 1.3× 407 1.1× 135 3.1k
Carlo Barone Italy 31 2.3k 1.1× 671 0.7× 1.4k 1.5× 769 1.9× 495 1.3× 130 3.6k
P Rougier France 16 3.1k 1.5× 959 1.0× 1.2k 1.3× 617 1.6× 200 0.5× 70 3.9k
Cristina Grávalos Spain 23 1.7k 0.8× 426 0.5× 960 1.1× 514 1.3× 319 0.8× 81 2.3k

Countries citing papers authored by D. Depisch

Since Specialization
Citations

This map shows the geographic impact of D. Depisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Depisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Depisch more than expected).

Fields of papers citing papers by D. Depisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Depisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Depisch. The network helps show where D. Depisch may publish in the future.

Co-authorship network of co-authors of D. Depisch

This figure shows the co-authorship network connecting the top 25 collaborators of D. Depisch. A scholar is included among the top collaborators of D. Depisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Depisch. D. Depisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vormittag, Laurenz, Gabriela Kornek, A. Lenauer, et al.. (2007). UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer – a retrospective analysis. Anti-Cancer Drugs. 18(6). 709–712. 14 indexed citations
2.
Ulrich-Pur, H., Gabriela Kornek, K. Haider, et al.. (2006). Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer. Acta Oncologica. 46(2). 208–213. 10 indexed citations
3.
Kornek, Gabriela, B. Schuell, Friedrich Laengle, et al.. (2004). Mitomycin C in combination with capecitabine or biweeklyhigh-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Annals of Oncology. 15(3). 478–483. 110 indexed citations
4.
Scheithauer, Werner, B. Schüll, H. Ulrich-Pur, et al.. (2002). Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial. Annals of Oncology. 14(1). 97–104. 149 indexed citations
5.
Pohl, Gudrun, Thomas Stranzl, D. Depisch, et al.. (2001). Expression of the lung resistance protein in primary colorectal carcinomas.. PubMed. 21(1A). 201–4. 3 indexed citations
6.
Kornek, Gabriela, H. Ulrich-Pur, K. Haider, et al.. (2001). Treatment of Advanced Breast Cancer with Vinorelbine and Docetaxel With or Without Human Granulocyte Colony-Stimulating Factor. Journal of Clinical Oncology. 19(3). 621–627. 36 indexed citations
7.
Pohl, Gudrun, et al.. (2000). Expression of the lung resistance protein (LRP) in primary breast cancer.. PubMed. 19(6B). 5051–5. 18 indexed citations
8.
Filipits, Martin, R. Malayeri, Gudrun Pohl, et al.. (2000). Expression of the multidrug resistance protein (MRP1) in breast cancer.. PubMed. 19(6B). 5043–9. 26 indexed citations
9.
Kwasny, W., Gabriela Kornek, K. Haider, et al.. (2000). Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor. Breast Cancer Research and Treatment. 63(3). 235–241. 3 indexed citations
10.
Kornek, Gabriela, A Marczell, D. Depisch, et al.. (2000). Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. British Journal of Cancer. 82(1). 98–103. 46 indexed citations
11.
Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (1999). Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. British Journal of Cancer. 80(11). 1797–1802. 39 indexed citations
12.
Scheithauer, Werner, H. Ulrich-Pur, Markus Raderer, et al.. (1999). Phase II trial of high-dose gemcitabine in patients with metastatic pancreatic adenocarcinoma. European Journal of Cancer. 35. S147–S147. 3 indexed citations
13.
Scheithauer, Werner, A Marczell, J. Karner, et al.. (1998). Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. British Journal of Cancer. 77(8). 1349–1354. 72 indexed citations
14.
Dekan, Gerhard, et al.. (1997). Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. British Journal of Cancer. 75(2). 208–212. 29 indexed citations
15.
Zöchbauer‐Müller, Sabine, J. Wallner, K. Haider, et al.. (1997). MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas. European Journal of Cancer. 33(9). 1516–1518. 5 indexed citations
16.
Filipits, Martin, Gerhard Dekan, K. Haider, et al.. (1996). MRP and MDR1 gene expression in primary breast carcinomas.. PubMed. 2(7). 1231–7. 76 indexed citations
17.
Depisch, D., et al.. (1996). Combined Locoregional and Systemic Adjuvant Chemotherapy of Stage II and III Rectal Carcinoma. Oncology Research and Treatment. 19(2). 147–151. 3 indexed citations
18.
Scheithauer, Werner, D. Depisch, Gabriela Kornek, et al.. (1994). Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer. Cancer. 73(6). 1562–1568. 23 indexed citations
19.
20.
Kornek, Gabriela, D. Depisch, Eva M. Temsch, & Werner Scheithauer. (1991). Comparative analysis of cancer-associated antigen CA-195, CA19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. Journal of Cancer Research and Clinical Oncology. 117(5). 493–496. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuhiko Shirasaka Breakdown of academic impact, for papers by J. L. Misset Breakdown of academic impact, for papers by Elizabeth Poplin Breakdown of academic impact, for papers by Rainer Porschen Breakdown of academic impact, for papers by Carles Pericay Breakdown of academic impact, for papers by Roger Faroux Breakdown of academic impact, for papers by Roberto Petrioli Breakdown of academic impact, for papers by Carlo Barone Breakdown of academic impact, for papers by P Rougier Breakdown of academic impact, for papers by Cristina Grávalos
Rankless by CCL
2026